AEPCX
Price
$58.34
Change
+$0.18 (+0.31%)
Updated
Jun 6 closing price
Net Assets
133.45B
AFCNX
Price
$18.54
Change
+$0.05 (+0.27%)
Updated
Jun 6 closing price
Net Assets
132.2M
Interact to see
Advertisement

AEPCX vs AFCNX

Header iconAEPCX vs AFCNX Comparison
Open Charts AEPCX vs AFCNXBanner chart's image
American Funds EUPAC C
Price$58.34
Change+$0.18 (+0.31%)
VolumeN/A
Net Assets133.45B
American Century Focused Intl Gr I
Price$18.54
Change+$0.05 (+0.27%)
VolumeN/A
Net Assets132.2M
AEPCX vs AFCNX Comparison Chart
Loading...
View a ticker or compare two or three
VS
AEPCX vs. AFCNX commentary
Jun 07, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is AEPCX is a Buy and AFCNX is a StrongBuy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
AEPCX has more cash in the bank: 133B vs. AFCNX (132M). AEPCX pays higher dividends than AFCNX: AEPCX (0.32) vs AFCNX (0.00). AEPCX was incepted earlier than AFCNX: AEPCX (24 years) vs AFCNX (9 years). AEPCX (1.59) is less costly to investors than AFCNX (1.09). AFCNX is a more actively managed with annual turnover of: 82.00 vs. AEPCX (30.00). AEPCX has a lower initial minimum investment than AFCNX: AEPCX (250) vs AFCNX (2500). AFCNX annual gain was more profitable for investors over the last year : 8.45 vs. AEPCX (1.93). AFCNX return over 5 years is better than : 29.82 vs. AEPCX (14.63).
AEPCXAFCNXAEPCX / AFCNX
Total Expense Ratio1.591.09146%
Annual Report Gross Expense Ratio1.591.09146%
Fund Existence24 years9 years-
Gain YTD12.90912.951100%
Front LoadN/AN/A-
Min. Initial Investment250250010%
Min. Initial Investment IRAN/AN/A-
Net Assets133B132M100,758%
Annual Yield % from dividends0.320.00-
Returns for 1 year1.938.4523%
Returns for 3 years14.7421.6068%
Returns for 5 years14.6329.8249%
Returns for 10 years21.44N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
OBIO3.310.26
+8.52%
Orchestra BioMed Holdings
SES1.040.07
+6.97%
SES AI Corp
ENVB1.300.04
+3.17%
Enveric Biosciences Inc
TMDX139.053.46
+2.55%
TransMedics Group
REXR36.030.48
+1.35%
Rexford Industrial Realty